Human CLEC1B/1810061I13Rik/CLEC2 ORF/cDNA clone-Adenovirus plasmid (NM_001099431.1)
Cat. No.: pGMAD000045
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CLEC1B/1810061I13Rik/CLEC2 adenoviral expression plasmid for CLEC1B adenovirus packaging, CLEC1B adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go to
CLEC2/CLEC1B/CLEC1B/1810061I13Rik products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMAD000045 |
| Gene Name | CLEC1B |
| Accession Number | NM_001099431.1 |
| Gene ID | 51266 |
| Species | Human |
| Product Type | Adenovirus plasmid (overexpression) |
| Insert Length | 591 bp |
| Gene Alias | 1810061I13Rik,CLEC2,CLEC2B,PRO1384,QDED721 |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGCAGGATGAAGATGGATACATCACCTTAAATATTAAAACTCGGAAACCAGCTCTCATCTCCGCTGTCATGCAGCGCAATTACCTACAAGGTGAGAATGAAAATCGCACAGGAACTCTGCAACAATTAGCAAAGCGCTTCTGTCAATATGTGGTAAAACAATCAGAACTAAAGGGCACTTTCAAAGGTCATAAATGCAGCCCCTGTGACACAAACTGGAGATATTATGGAGATAGCTGCTATGGGTTCTTCAGGCACAACTTAACATGGGAAGAGAGTAAGCAGTACTGCACTGACATGAATGCTACTCTCCTGAAGATTGACAACCGGAACATTGTGGAGTACATCAAAGCCAGGACTCATTTAATTCGTTGGGTCGGATTATCTCGCCAGAAGTCGAATGAGGTCTGGAAGTGGGAGGATGGCTCGGTTATCTCAGAAAATATGTTTGAGTTTTTGGAAGATGGAAAAGGAAATATGAATTGTGCTTATTTTCATAATGGGAAAATGCACCCTACCTTCTGTGAGAACAAACATTATTTAATGTGTGAGAGGAAGGCTGGCATGACCAAGGTGGACCAACTACCTTAA |
| ORF Protein Sequence | MQDEDGYITLNIKTRKPALISAVMQRNYLQGENENRTGTLQQLAKRFCQYVVKQSELKGTFKGHKCSPCDTNWRYYGDSCYGFFRHNLTWEESKQYCTDMNATLLKIDNRNIVEYIKARTHLIRWVGLSRQKSNEVWKWEDGSVISENMFEFLEDGKGNMNCAYFHNGKMHPTFCENKHYLMCERKAGMTKVDQLP |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-MP0292-Ab | Anti-CLC1B/ CLEC1B/ 1810061I13Rik monoclonal antibody |
| Target Antigen | GM-Tg-g-MP0292-Ag | CLEC1B VLP (virus-like particle) |
| ORF Viral Vector | pGMLV001230 | Human CLEC1B Lentivirus plasmid |
| ORF Viral Vector | pGMAD000045 | Human CLEC1B Adenovirus plasmid |
| ORF Viral Vector | vGMLV001230 | Human CLEC1B Lentivirus particle |
| ORF Viral Vector | vGMAD000045 | Human CLEC1B Adenovirus particle |
Target information
| Target ID | GM-MP0292 |
| Target Name | CLEC2/CLEC1B |
|
Gene Group Identifier (Target Gene ID in Homo species) |
51266 |
| Gene ID |
100053758 (Equus caballus), 109491361 (Felis catus), 500336 (Rattus norvegicus), 51266 (Homo sapiens) 56760 (Mus musculus), 717404 (Macaca mulatta), 784092 (Bos taurus) |
| Gene Symbols & Synonyms | CLEC1B,Clec1b,RGD1563517,CLEC2,CLEC2B,PRO1384,QDED721,1810061I13Rik,Clec2,Clec-2 |
| Target Alternative Names | 1810061I13Rik,C-type lectin domain family 1 member B,C-type lectin-like receptor 2 (CLEC-2),CLEC1B,CLEC2,CLEC2B,Clec-2,Clec1b,Clec2,PRO1384,QDED721,RGD1563517 |
| Uniprot Accession |
Q9JL99,Q9P126
Additional SwissProt Accessions: Q9P126,Q9JL99 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | |
| Disease | |
| Disease from KEGG | C-type lectin receptor signaling pathway |
| Gene Ensembl | ENSECAG00000003385, ENSG00000165682, ENSMUSG00000030159, ENSMMUG00000002955, ENSBTAG00000030423 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


